Novartis AG
If you can't build the next Ozempic, buy it: Where M&A could be heading in the obesity drug space
Investors are contemplating where and when the next big obesity drug deal will occur. At the moment, Novo Nordisk and Eli Lilly have the growing obesity drug market all to themselves. But given the potential size of this opportunity, which some have put at more than $100 billion by 2030 , other pharmaceuticals companies — […]
Read More
European shares near reduced as buyers assess world wide information, earnings Sanofi falls 18%
European shares closed reduce on Friday, with earnings and the state of the global financial state maintaining sentiment on edge. The benchmark Stoxx 600 provisionally ended down .8%, with most sectors and key bourses in adverse territory. Health care stocks slipped 2.8% to lead losses, though chemical substances shares climbed .8%. The pan-European index has […]
Read More
Novartis unit Sandoz set to start trading after completing spinoff
Novartis said in August that it plans to spin off its generics unit Sandoz to sharpen its focus on its patented prescription medicines. Bloomberg | Bloomberg | Getty Images Novartis has completed the spinoff of its generics and biosimilars business Sandoz, which is set to debut trading on the SIX Swiss Exchange on Wednesday. The […]
Read More
Drugmakers opt in to Medicare drug price negotiations – here’s what happens next
A pharmacist holds a bottle of the drug Eliquis, made by Pfizer Pharmaceuticals, at a pharmacy in Provo, Utah, January 9, 2020. George Frey | Reuters All drugmakers of the first 10 medicines selected for Medicare drug price negotiations have agreed to participate in the talks, even after many of them sued to halt the […]
Read More
Biden administration unveils first 10 drugs subject to Medicare price negotiations
Kubra Cavus | Istock | Getty Images The Biden administration on Tuesday unveiled the first 10 prescription drugs that will be subject to price negotiations between manufacturers and Medicare, kicking off a controversial process that aims to make costly medications more affordable for older Americans. President Joe Biden’s Inflation Reduction Act, which passed in a […]
Read More
The ADHD drug market is already stretched thin. Now it’s facing a back-to-school supply strain
Ten milligram tablets of the hyperactivity drug, Adderall, made by Shire Plc. Jb Reed | Bloomberg | Getty Images It’s been 10 months since the Food and Drug Administration first announced a nationwide shortage of Adderall — one of the most widely used medications for attention deficit hyperactivity disorder — and the supply strain could […]
Read More
CVS pushes into making cheaper versions of complex drugs with new discount Humira
Rafael Henrique | Lightrocket | Getty Images CVS Health is partnering with drugmaker Sandoz to produce a near identical version of the blockbuster arthritis treatment Humira that will sell for 80% below the price of the brand-named drug. The move is part of the company’s new venture focused on securing, and in some cases co-producing, […]
Read More
Novartis programs Sandoz spin-off around Oct. 4, proposes share
Novartis engineers in packaging facility. Resource: Novartis Novartis on Friday proposed to present shareholders a person Sandoz share for each five Novartis shares as it claimed it planned to spin off the generic medications division on or all around Oct. 4. The Swiss drugmaker invited shareholders to an incredible basic meeting on Sept. 15 just […]
Read More
Europe stocks close 1.4% lower as investors digest U.S. rating downgrade
Europe stocks close lower The Stoxx 600 index fell for a second consecutive session Wednesday to a more than two-week low. Germany’s DAX and the U.K.’s FTSE 100 both declined by around 1.36% as France’s CAC 40 dropped 1.26%. Stock Chart IconStock chart icon Stoxx 600 index. Economists doubt U.S. debt downgrade will have lasting […]
Read More
‘Good price, lower threat, large quality’: BofA names leading Europe shares to beat a recession
Financial institution of America has named several European “leading shares” it claims are of “excellent price, very low hazard” and “superior excellent.” All of them turned up on “economic downturn screens” for July, in a market place BofA explained as a being in a recession model cycle. A model cycle refers to the marriage among […]
Read More